HONZEPH Trademark

Trademark Overview

On Tuesday, August 26, 2014, a trademark application was filed for HONZEPH with the United States Patent and Trademark Office. The USPTO has given the HONZEPH trademark a serial number of 86377291. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 17, 2024. This trademark is owned by Glaxo Group Limited. The HONZEPH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
honzeph

General Information

Serial Number86377291
Word MarkHONZEPH
Filing DateTuesday, August 26, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 17, 2024
Registration Number5326535
Registration DateTuesday, November 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, June 1, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 29, 2014NEW APPLICATION ENTERED
Tuesday, September 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 10, 2014ASSIGNED TO EXAMINER
Wednesday, December 10, 2014SUSPENSION LETTER WRITTEN
Wednesday, December 10, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, December 10, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 8, 2015ASSIGNED TO LIE
Monday, June 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 17, 2015SUSPENSION INQUIRY WRITTEN
Wednesday, June 17, 2015INQUIRY TO SUSPENSION E-MAILED
Wednesday, June 17, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, June 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 26, 2015ASSIGNED TO LIE
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, July 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2015PUBLISHED FOR OPPOSITION
Tuesday, August 4, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 3, 2016SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2016SOU EXTENSION 1 FILED
Tuesday, April 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 11, 2016SOU EXTENSION 1 GRANTED
Tuesday, April 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, August 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 12, 2016SOU EXTENSION 2 FILED
Tuesday, October 11, 2016SOU EXTENSION 2 GRANTED
Wednesday, October 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2017SOU EXTENSION 3 FILED
Wednesday, March 29, 2017SOU EXTENSION 3 GRANTED
Friday, March 31, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, October 5, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 7, 2017REGISTERED-PRINCIPAL REGISTER
Monday, November 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 17, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

honzeph pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological